Lexology June 2, 2023
Skadden Arps Slate Meagher & Flom LLP

We are pleased to present the first issue of our newsletter analyzing recent trends and developments impacting the life sciences industry, including DOJ policy updates and key provisions of the Food and Drug Omnibus Reform Act.

What Life Sciences Companies Need To Know About Recent Changes to DOJ Policies

In the first quarter of 2023, the Department of Justice (DOJ) announced a series of updates to existing policies, as well as some entirely new policies, relating to the prosecution of corporate crime and the corresponding evaluation of corporate compliance programs.

These DOJ policies apply across industries, but...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Pharma / Biotech, Regulations
Boosting biopharma R&D performance with a next-generation technology stack
Charting the path to patients
External innovation: Biopharma dealmaking to boost R&D productivity
Building a shared vision for pharma R&D–supplier partnerships
Healthcare Industry Trends – 2024 Annual Report

Share This Article